[What is new in the indication for and monitoring of lung transplants].
Mihălţan
F
F
Institutul Naţional de Pneumologie Marius Nasta Bucureşti.
Ulmeanu
R
R
Prisăcaru
L
L
Chiotan
R
R
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004608:Eligibility Determination; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000379:methods* / Q000502:physiology; D008991:Monitoring, Physiologic / Q000639:trends*; D011182:Postoperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000188:drug therapy; D011300:Preoperative Care; D016019:Survival Analysis
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents